Nutra Pharma Corp (NPHC) earnings
Quarterly results of Nutra Pharma Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Nutra Pharma Corp was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Nutra Pharma Corp reported revenue of $34.5K (-59.2% on the same quarter a year earlier) and a net loss of $3.9M.
Diluted earnings per share were $0.00.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $34.5K | -59.2% | -$3.9M | $0.00 |
| Q1 FY2026 | $27.2K | -63.2% | -$459.7K | $0.00 |
| Q4 FY2025 | $28.9K | -64.7% | -$488.5K | - |
| Q3 FY2025 | $70.2K | -6.3% | -$523.5K | $0.00 |
| Q2 FY2025 | $84.5K | - | $369.6K | $0.00 |
| Q1 FY2025 | $74K | - | -$1.4M | $0.00 |
| Q4 FY2024 | $81.9K | - | -$230.9K | - |
| Q3 FY2024 | $75K | - | -$260.7K | $0.00 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
When is Nutra Pharma Corp's next earnings date?
Nutra Pharma Corp was expected to report around October 15, 2026; nothing is on file with the SEC yet.
What were Nutra Pharma Corp's latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Nutra Pharma Corp reported revenue of $34.5K and a net loss of $3.9M. The figures come from its filing with the SEC.
Is Nutra Pharma Corp's revenue growing?
Revenue in Q2 FY2026 was $34.5K, down 59.2% from $84.5K in the same quarter a year earlier.
Get an email when NPHC reports
Follow NPHC and we email you its next results the day they are filed, with the numbers explained.